NexGen™ titanium metal powder now qualified for use by BoeingMONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, is pleased to announce today that the Company has received of ...

Immunovant’s new management team is focused on rapid clinical execution for the six announced indications for IMVT-1402, including a second potentially registrational study in Graves’ disease (GD) and a potentially registrational study in Sjögren’s disease (SjD), both expected to start in summer 2025Positive data from first-generation batoclimab trials in myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP) demonstrated that deeper IgG reductions correlated with improved clini ...

Lantronix Director to Speak on “Out-of-Band Everywhere!”IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that it will do live demos and daily giveaways of its LM4 AI-driven Out-of-Band Management (OOBM) platform at booth 3219 at Cisco Live held June 9–12, 2025, in San Diego. Lantronix, a Cisco Devnet Partner, has the most complete portfolio of out-of-band management con ...

BASEL, Switzerland and LONDON and NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2025, and provided a business update. Brepocitinib program progressing well with rapid enrollment in non-infectious uveitis (NIU) Phase 3 study and first patients dosed in cutaneous sarcoidosis (CS) proof-of-concept trial, with readouts expected in the first half of calendar year 2027 and second half of calendar year 2 ...

MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, will report its financial results for the second quarter ended April 30, 2025, on Thursday, June 12, 2025, before markets open. Management will hold a conference call to discuss its financial results the same day at 10:00 a.m. ET. The conference call will include a Q&A period open exclusively to financial analysts who are invited to participate by using th ...

Core Insights - Plug Power Inc. achieved a significant milestone by producing 300 metric tons of liquid hydrogen in April 2025, marking the highest monthly output for the facility and setting a new benchmark for the U.S. hydrogen industry [1][3] Company Overview - Plug Power operates the largest electrolytic liquid hydrogen production facility in the U.S., located in Woodbine, Georgia, which opened in January 2024 and has a nameplate capacity of 15 tons per day [2][3] - The company is a leader in comprehensive hydrogen solutions, providing a fully integrated ecosystem that includes production, storage, delivery, and power generation [6][7] Production Capacity and Technology - The Georgia facility is part of Plug's hydrogen generation network, which includes operational plants in Georgia, Tennessee, and Louisiana, collectively producing 40 tons of hydrogen per day, making Plug the largest producer of liquid hydrogen in the U.S. [3][7] - The facility utilizes Plug's proprietary GenEco proton exchange membrane (PEM) electrolyzer technology, demonstrating scalability, reliability, and cost-competitiveness [2][4] Market Demand and Customer Base - The performance of the Georgia plant reflects strong market demand for Plug's GenEco electrolyzers, enhancing customer value and supporting long-term commercial growth [4] - Hydrogen produced at the Georgia plant is supplied to key customers in logistics and distribution, including Walmart, Amazon, and Home Depot, aiding their decarbonization efforts [4][8]

Company Overview - Cullinan Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies across various modalities for autoimmune diseases and cancer [3] - The company has built a diversified portfolio of clinical-stage assets aimed at inhibiting key disease drivers and harnessing the immune system [3] - Cullinan aims to create new standards of care by identifying optimal targets and developing transformative therapeutics [3] Upcoming Events - The management team will host a company event at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL [1] - An in-person event for analysts and institutional investors is scheduled for June 1, 2025, at 6:30 p.m. CT, following the oral presentation of results from the pivotal Phase 2b REZILIENT1 trial [4] - Participation in the Jefferies 2025 Global Healthcare Conference will include a panel discussion on June 4, 2025, and a company presentation on June 5, 2025 [4] Investor Relations - Webcasts of the ASCO event and Jefferies Conference presentations will be available on the company's investor relations website [2] - Investors and analysts can register for the in-person event by contacting the Head of Investor Relations [4]

NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the Company’s participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will participate in a fireside chat on Thursday, June 5, 2025 at 9:55 a.m. EDT in New York City and will host one-on-one ...

Baker Hughes will supply 16 NovaLT™ gas turbines for data center projects in the U.S. Award builds on the collaboration announced in March 2025 between Baker Hughes and Frontier HOUSTON and LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Wednesday an award from Frontier Infrastructure Holdings (“Frontier”), a Tailwater Capital LLC portfolio company, for 16 NovaLT™ gas turbines to power its data center projects in Wyoming and Texas, delivering up ...

REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument—its most advanced solution yet for scalable, high-resolution, mass spec-based proteomics. Seer’s newest innovation, debuting at the upcoming American Society for Mass Spectrometry (ASMS) annual conference in Baltimore, MD, ov ...